Researchers define new subtypes of common brain disorder
Researchers at WashU have used AI tools to describe three sub-types of Chiari type-1, which will help guide clinicians to make the most effective treatment decisions for their patients.
University departments win CASE awards
Content and projects produced by University Marketing & Communications and other departments across WashU recently won national and several regional awards from the Council for Advancement and Support of Education.
New drug targets for Alzheimer’s identified from cerebrospinal fluid
Researchers at WashU Medicine have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and progression.
Vaccine shows promise against aggressive breast cancer
A small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
WashU Medicine, BJC Health System launch Center for Health AI
Washington University School of Medicine in St. Louis and BJC Health System have launched the joint Center for Health AI. The center will focus on making care more personalized and effective for patients and more efficient and manageable for physicians, nurses and all those striving to ensure patients receive the best care.
Yoo receives grant from Hereditary Disease Foundation
Andrew Yoo, a professor of developmental biology at WashU Medicine, has received the 2024 Transformative Research Award, a two-year $1 million grant from the Hereditary Disease Foundation.
Wrighton named to Ingram’s top 50 leaders
Mark S. Wrighton, chancellor emeritus and the James and Mary Wertsch Distinguished University Professor at WashU, has been named to Ingram’s Magazine’s list of 50 power players and leaders in business.
Researchers solve medical mystery of neurological symptoms in kids
Researchers at WashU Medicine collaborated with an international team of doctors and scientists to identify the cause of a rare genetic disorder involving intellectual disability and brain malformations.
Jin receives NIH grant to study congenital hydrocephalus
Sheng Chih (Peter) Jin, an assistant professor of genetics at WashU Medicine, has received a $3.2 million grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) to study the genetic and molecular underpinnings of congenital hydrocephalus.
Complexity of tumors revealed in 3D
A new analysis led by WashU Medicine researchers has revealed detailed 3D maps of the internal structures of multiple tumor types. These maps could lead to new approaches to therapy.
View More Stories